Thomas Trimarchi, the President and CFO of $BBIO, sold 1,973 shares of the company on 08-18-2025 for an estimated $100,512. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.4% of their shares of this class of stock. Following this trade, they now own 463,318 shares of this class of $BBIO stock.
$BBIO Insider Trading Activity
$BBIO insiders have traded $BBIO stock on the open market 47 times in the past 6 months. Of those trades, 0 have been purchases and 47 have been sales.
Here’s a breakdown of recent trading of $BBIO stock by insiders over the last 6 months:
- GENETIC DISORDER L.P. KKR has made 0 purchases and 2 sales selling 12,000,000 shares for an estimated $402,960,000.
- GLOBAL INVESTORS LP VIKING sold 3,500,000 shares for an estimated $154,000,000
- NEIL KUMAR (Chief Executive Officer) has made 0 purchases and 23 sales selling 517,699 shares for an estimated $19,435,103.
- CHARLES J HOMCY has made 0 purchases and 3 sales selling 300,000 shares for an estimated $13,912,442.
- FRANK MCCORMICK sold 100,000 shares for an estimated $4,422,800
- ANDREW LO sold 100,000 shares for an estimated $3,849,900
- ANDREA ELLIS has made 0 purchases and 3 sales selling 57,167 shares for an estimated $2,212,683.
- THOMAS TRIMARCHI (President and CFO) has made 0 purchases and 2 sales selling 17,353 shares for an estimated $871,722.
- HANNAH VALANTINE has made 0 purchases and 6 sales selling 21,874 shares for an estimated $798,506.
- BRIAN C STEPHENSON (CFO and Treasurer) has made 0 purchases and 3 sales selling 12,648 shares for an estimated $432,088.
- MARICEL APULI (Chief Accounting Officer) has made 0 purchases and 2 sales selling 2,026 shares for an estimated $84,949.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$BBIO Hedge Fund Activity
We have seen 221 institutional investors add shares of $BBIO stock to their portfolio, and 156 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- KOHLBERG KRAVIS ROBERTS & CO. L.P. removed 6,000,000 shares (-31.2%) from their portfolio in Q2 2025, for an estimated $259,080,000
- VIKING GLOBAL INVESTORS LP removed 3,500,000 shares (-15.9%) from their portfolio in Q2 2025, for an estimated $151,130,000
- CITADEL ADVISORS LLC removed 2,598,708 shares (-88.7%) from their portfolio in Q2 2025, for an estimated $112,212,211
- FARALLON CAPITAL MANAGEMENT LLC added 2,169,000 shares (+37.8%) to their portfolio in Q2 2025, for an estimated $93,657,420
- JANUS HENDERSON GROUP PLC added 2,105,133 shares (+29.4%) to their portfolio in Q2 2025, for an estimated $90,899,642
- MACQUARIE GROUP LTD added 2,003,713 shares (+2189.3%) to their portfolio in Q2 2025, for an estimated $86,520,327
- D. E. SHAW & CO., INC. added 1,998,104 shares (+2403.0%) to their portfolio in Q2 2025, for an estimated $86,278,130
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$BBIO Analyst Ratings
Wall Street analysts have issued reports on $BBIO in the last several months. We have seen 13 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Cantor Fitzgerald issued a "Overweight" rating on 07/29/2025
- Jefferies issued a "Buy" rating on 07/14/2025
- Citigroup issued a "Buy" rating on 07/11/2025
- Oppenheimer issued a "Outperform" rating on 07/09/2025
- Wells Fargo issued a "Overweight" rating on 06/30/2025
- B of A Securities issued a "Buy" rating on 06/25/2025
- Wolfe Research issued a "Outperform" rating on 06/17/2025
To track analyst ratings and price targets for $BBIO, check out Quiver Quantitative's $BBIO forecast page.
$BBIO Price Targets
Multiple analysts have issued price targets for $BBIO recently. We have seen 14 analysts offer price targets for $BBIO in the last 6 months, with a median target of $63.5.
Here are some recent targets:
- Greg Harrison from Scotiabank set a target price of $57.0 on 08/06/2025
- Leland Gershell from Oppenheimer set a target price of $61.0 on 08/06/2025
- Josh Schimmer from Cantor Fitzgerald set a target price of $95.0 on 07/29/2025
- Danielle Brill from Truist Securities set a target price of $66.0 on 07/21/2025
- Biren Amin from Piper Sandler set a target price of $68.0 on 07/14/2025
- Andrew Tsai from Jefferies set a target price of $70.0 on 07/14/2025
- David Lebowitz from Citigroup set a target price of $67.0 on 07/11/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
